Tag: Proton Pump Inhibitors
Cumulative PPI Use for More Than 4.4 Years Linked to Increased Risk for Dementia
No significant association seen for lesser durations of proton pump inhibitor use
ASN: PPI Use May Up Risk for AKI After Cardiac Surgery
Adults receiving proton pump inhibitors have increased risk for acute kidney injury requiring dialysis following cardiac surgery
Proton Pump Inhibitor Use Tied to Less Severe Periodontal Disease
Patients with periodontitis who use proton pump inhibitors have fewer teeth with elevated probing depths for the gap between teeth and gums
Add-On PPI Therapy May Improve Glycemic Control in Diabetes
However, treatment with proton pump inhibitors is not associated with risk for incident diabetes in the general population
Child Proton Pump Inhibitor Use May Increase Asthma Risk
Risk increased across all age groups with highest risk for infants and toddlers; risk seen across individual PPIs
Proton Pump Inhibitor Use Linked to Increased T2DM Risk
Type 2 diabetes risk increased with increasing length of PPI use, particularly use for more than two years
PPI Use Is Negative Prognostic Marker in Urothelial Cancer
PPI use linked to significantly worse progression-free, overall survival in advanced urothelial cancer
Risk for COVID-19 Increased for Adults Taking PPIs
Dose-response relationship observed; risk up 3.67-fold for those using PPIs up to twice daily
Guidelines Issued for Managing Eosinophilic Esophagitis
Topical glucocorticosteroids recommended over no treatment
Suppressing Stomach Acid May Up Intestinal Growth of MDROs
Gastric acid suppression increased odds of intestinal colonization with MDROs by about 75 percent